Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Tables)

v3.21.1
Share Capital (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of stock option activities and related information
    Number of ordinary
shares
    Number of ordinary
shares
 
    Authorized     Issued and outstanding     Authorized     Issued and outstanding  
    December 31,
2019
    December 31,
2018
 
                                 
Ordinary shares     200,000,000       24,393,218       200,000,000       23,491,948  
Schedule of options granted outstanding and exercise prices
    Number of options     Weighted average exercise price    

Weighted average remaining contractual

life
(years)

    Aggregate intrinsic-value  
                         
Outstanding as of January 1, 2019     1,714,039     $ 0.63                  
Granted     207,500       0.27                  
Options forfeited     (107,158 )   $ 0.88                  
                                 
Outstanding as of December 31, 2019     1,814,381     $ 0.58       6.66     $ 24,538  
                                 
Exercisable as of December 31, 2019     1,209,464     $ 0.68       5.72     $ 24,538  
Schedule of options granted to officers, directors, employees, consultants and service providers
    Outstanding     Exercisable  
Exercise price   Number of options     Weighted average remaining contractual life (years)     Number of options     Weighted average remaining contractual life (years)  
                         
(*)     230,425       3.4       230,425       3.4  
$0.03     19,597       5.8       19,597       5.8  
0.27     809,000       8.6       291,125       8.4  
0.34     8,020       3.9       8,020       3.9  
0.45     63,097       0.7       63,097       0.7  
0.92     650,424       6.2       563,382       6.0  
4.72     1,068       2.2       1,068       2.2  
5.05     2,769       2.2       2,769       2.2  
$5.73     29,981       3.8       29,981       3.8  
      1,814,381               1,209,464          
(*) Represents an amount lower than $0.01.
Schedule of stock based compensation
    Year Ended December 31,  
    2019     2018     2017  
                   
Research and Development   $ 16,295     $ 36,723     $ 17,956  
Sales and Marketing     7,209       14,837       9,747  
General and Administrative     86,109       102,430       108,431  
                         
    $ 109,613     $ 153,990     $ 136,134  
Schedule of outstanding warrants
Outstanding     Issuance year   Exercise price     Exercisable through    
                     
  117,209     2009   $ (* )     Exit event   (**)
  59,384     2013     0.92     2023   (**)
  600,000     2018     0.50     2023   Refer to Note 8c
  170,000     2018     0.50     2023   Refer to Note 8d
  466,667     2018   $ 0.50     2023   Refer to Note 11b10
                         
  1,413,260                      
(*) Represents an amount lower than $0.01
(**) Issued in connection with the 2013 and 2009 arrangements